Repligen RGEN Return on equity

Return on equity at other companies

Thermo Fisher ScientificTMO

13.5%+0.1pp

DanaherDHR

7.6%+1.0pp

Maravai LifeSciences Holdings, Inc.MRVI

-40.8%-4.0pp

Bio-Rad LaboratoriesBIO

2.5%+1.3pp

Charles River LaboratoriesCRL

-7.7%—

TEC

Bio-TechneTECH

6.5%-3.9pp

FAQ

What is Repligen's return on equity?

Repligen (RGEN) reported return on equity of 2% in Q2 2026.

How has Repligen's return on equity changed year-over-year?

Repligen's return on equity increased by 391.2% year-over-year, from -0.7% to 2%.

What is the long-term trend for Repligen's return on equity?

Over 4 years (2020 to 2025), Repligen's return on equity has grown at a -15.2% compound annual growth rate (CAGR), from 4.6% to 2.4%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.